Facebook
Twitter
Telegram
Report an ErrorCan-Fite BioPharma Ltd. Balance Sheet 2011-2024 | CANF
Annual Balance Sheet Can-Fite BioPharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | -3.5 M | -8.11 M | -16.9 M | -9.27 M | -5.96 M | -1.15 M | -3.84 M | ||
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | 43 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
1.73 M | 2.31 M | 3.14 M | 2.18 M | 2.46 M | 1.82 M | 2.98 M | 3.79 M | 5.38 M | 1.85 M | 37 K | 18.2 K | 258 K |
Total Current Liabilities |
2.02 M | 2.5 M | 2.73 M | 1.27 M | 3.27 M | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 3.45 M | 7.3 M | 4.94 M | 4.78 M | 6.29 M | 7.16 M | 3.33 M | 2.18 M | 2.34 M | 1.61 M |
Deferred Revenue |
622 K | 783 K | 818 K | 334 K | 469 K | 926 K | 374 K | 322 K | 220 K | - | - | - | - |
Retained Earnings |
-158 M | -151 M | -141 M | -125 M | -110 M | -101 M | -106 M | -91 M | -82.7 M | -78.1 M | -80.5 M | -67.3 M | -60.8 M |
Total Assets |
9.99 M | 9.28 M | 20.3 M | 9.52 M | 8.17 M | 7.95 M | 7.83 M | 10.2 M | 17.6 M | 10.2 M | 6.63 M | 1.64 M | 4.9 M |
Cash and Cash Equivalents |
- | - | - | 8.27 M | 2.7 M | - | - | - | - | - | - | - | - |
Book Value |
- | - | 20.3 M | 6.07 M | 876 K | 3.02 M | 3.05 M | 3.87 M | 10.4 M | 6.86 M | 4.46 M | -708 K | 3.29 M |
Total Shareholders Equity |
6.24 M | 4.47 M | 14.4 M | 6.07 M | 2.44 M | 3.02 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Can-Fite BioPharma Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 71 K | - | 25 K | - | 24 K | - | 22 K | - | 39 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 3.14 M | - | 3.37 M | - | 2.18 M | - | 2.14 M | - | 2.46 M | - | - | - | 1.82 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 818 K | - | 1 M | - | 334 K | - | - | - | 469 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -141 M | - | -131 M | - | -125 M | - | -119 M | - | -110 M | - | - | - | -97.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 20.3 M | - | 9.68 M | - | 9.52 M | - | 12.8 M | - | 8.17 M | - | - | - | 7.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 4.39 M | - | 7.54 M | - | 8.27 M | - | 9.06 M | - | 2.7 M | - | 8.2 M | - | 3.62 M | - | - | - | 3.5 M | - | - | - | 8.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 20.3 M | - | 9.68 M | - | 9.52 M | - | 12.8 M | - | 8.17 M | - | - | - | 7.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 14.4 M | - | 3.96 M | - | 6.07 M | - | 9.16 M | - | 2.44 M | - | 8.44 M | - | 3.02 M | - | - | - | 2.98 M | - | - | - | 3.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency